Advocacy group urges Pfizer to sell more COVID-19 pills to developing countries

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 40 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 66%

Singapore Headlines News

Singapore Latest News,Singapore Headlines

NEW YORK: An influential consumer advocacy group is pressing Pfizer to supply more of its new COVID-19 pill Paxlovid to developing countries this year, concerned that access to the treatment will mirror inequalities in vaccines. Public Citizen sent a letter to Pfizer chief executive Albert Bourla on M

NEW YORK: An influential consumer advocacy group is pressing Pfizer to supply more of its new COVID-19 pill Paxlovid to developing countries this year, concerned that access to the treatment will mirror inequalities in vaccines.

Peter Maybarduk, director of Public Citizen's Access to Medicines program, said the letter was the opening salvo of what he expects will be a year-long campaign by the group. Pfizer's Paxlovid is expected to be a key tool in treating COVID-19 after a clinical trial showed that it reduced hospitalisations in high-risk patients by around 90 per cent. The results were significantly better than those from a clinical trial of Merck Inc's rival oral antiviral Molnupiravir.But supply of Paxlovid is extremely limited in the short term.

Pfizer did not immediately respond to requests for comment. The drugmaker's revenue in 2022 is expected to top US$100 billion, according to analyst estimates, more than half of that from sales of Paxlovid and its COVID-19 vaccine.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pfizer CEO sees annual Covid-19 vaccine rather than frequent boostersstraits_times 'So from a public health perspective, it is an ideal situation' - So, we adopt a public health policy based on what is said by a Big Pharma? straits_times Say someone who head a pharma company that produces a vaccine that is horseshit?
Source: STForeignDesk - 🏆 4. / 71 Read more »

South Korea reports second-highest Covid-19 count ahead of Lunar New Year holiday
Source: STForeignDesk - 🏆 4. / 71 Read more »

Egg freezing, destigmatising sex, COVID-19: What women will be talking about in 2022What issues will dominate this year? What will we be talking and hearing about most, and spending our money on? Experts share their forecast with CNA Women.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

A culture of collective responsibility: How Japan has kept COVID-19 numbers relatively lowTOKYO: On Jan 1 at a shrine in the leafy suburb of Asagaya in west Tokyo, Michiko Kubo and her husband, each wearing two face masks, joined a long line of worshippers all standing a metre apart to welcome 2022.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Fewer exhibitors at Singapore Airshow as Covid-19 concerns and restrictions bite
Source: straits_times - 🏆 5. / 69 Read more »

Europe could be headed for COVID-19 pandemic 'endgame': WHOCOPENHAGEN: The Omicron variant has moved the COVID-19 pandemic into a new phase and could bring it to an end in Europe, the WHO Europe director said Sunday (Jan 23). \u0022It\u0027s plausible that the region is moving towards a kind of pandemic endgame,\u0022 Hans Kluge told AFP in an interview, adding that Omicron coul
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »